ClinicalTrials.Veeva

Menu

Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status

Unknown

Conditions

Schizophrenia

Treatments

Dietary Supplement: glucose drink

Study type

Interventional

Funder types

Other

Identifiers

NCT01563016
selfcontrolvsglucose

Details and patient eligibility

About

The research aims to investigate the relationship between self-control ability and blood glucose level in schizophrenic patients. The main purpose of the present study is to explore whether the close relationship of blood glucose and self-regulatory strength observed in healthy individuals, is applicable to schizophrenic patients. More specifically, the current study aims

  • to investigate whether the exertion of self-control reduces blood glucose,
  • to examine whether low level of blood glucose deteriorates subsequent self-control performances
  • to examine whether restoring the glucose level eliminates these impairments, in schizophrenic patients.

Enrollment

100 estimated patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 15 or above
  • DSM-IV diagnosis of schizophrenia, schizoaffective disorder, schizophreniform psychosis, brief psychosis, psychosis NOS or delusional disorder
  • Cantonese-speaking Chinese
  • Ability to understand the nature of the study and sign informed consent

Exclusion criteria

  • Organic Brain disorder
  • Known history of intellectual disability
  • Priority Follow Up (Subtarget or Target)
  • All allergic to any sugar or artificial sweeteners
  • Diabetics
  • Physical Disability

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 4 patient groups, including a placebo group

Glucose & Depleting
Experimental group
Description:
participants will perform in a depleting task and receive a glucose drink
Treatment:
Dietary Supplement: glucose drink
Glucose & non-depleting
Placebo Comparator group
Description:
participants will perform in a non-depleting task and receive a glucose drink
Treatment:
Dietary Supplement: glucose drink
Placebo & depleting
No Intervention group
Description:
participants will perform in a depleting task and receive a placebo drink
Placebo & non depleting
No Intervention group
Description:
participants will perform in a non depleting task and receive a placebo drink

Trial contacts and locations

1

Loading...

Central trial contact

Eric YH Chen, MD; Chung-Ming Leung, Bsc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems